Toxicology Toolkit: Optimizing GI Decontamination and Activated Charcoal Use in Dogs and Cats

Présenté par Marie Holowaychuk, D.M.V., Dipl. ACVECC

Questionnaire de formation continue

Crédit de formation continue : 1

Nom

Questions

1. What is the median time to emesis for dogs when using ropinirole ophthalmic solution (Clevor®)? *
2. Which of the following is an absolute contraindication for emesis induction in dogs and cats? *
3. Why is the use of 3% Hydrogen Peroxide specifically contraindicated in feline patients? *
4. When treating a cat for toxin ingestion, which agent is currently recommended for emesis induction? *
5. Activated charcoal is known to have poor or no binding capacity for which of the following? *
6. Which charcoal formulation is often preferred for ease of administration and standardization, despite having a higher cost? *
7. In an unstable patient receiving activated charcoal via orogastric (OG) tube, which step is essential to prevent aspiration? *
8. What is the primary purpose of using Multi-Dose Activated Charcoal (MDAC) for specific toxins? *
9. Hypernatremia is a reported complication of charcoal administration; which patients are at the highest risk? *
10. For toxins that are highly protein-bound (e.g., NSAIDs, Baclofen), which advanced therapy should be considered? *